--- a
+++ b/clusters/9knumclustersv2/clust_1113.txt
@@ -0,0 +1,35 @@
+Current or prior use of immunosuppressive medication within  days prior to the first dose Additional Exclusion Criteria for Arm A
+Use of immunosuppressive medication at the time of enrollment
+Participant must not have current or prior use of immunosuppressive medication within  days prior to the first dose (with certain exceptions).
+Current or prior use of immunosuppressive medication within  days prior to the first dose (with certain exceptions).
+Current or prior use of immunosuppressive medication within  days before the first study treatment
+Current or prior use of immunosuppressive medication within  days prior to study entry
+Current or prior use of immunosuppressive medication within  days with some exceptions
+Current or prior use of immunosuppressive medication within  days prior to the first dose of study treatment
+Current or prior use of immunosuppressive medication within  days prior to the first dose (with certain exceptions).
+Prior use of levothyroxine
+Prior use of gossypol or AT-
+Current or prior use of immunosuppressive medication within  days prior to the first dose of MEDI
+Current use of immunosuppressive medication at study entry, with the following exceptions:
+Current use of immunosuppressive medication at the time of study enrollment.
+Current use of more than one antihypertensive medication.
+Current or prior use of immunosuppressive medication within  days with some exceptions.
+Concurrent or prior use of immunosuppressive medication with  days
+Subject use of immunosuppressive medication within  days before Cycle  Day .
+Current or prior use of immunosuppressive medication within  days prior to the first dose of study treatment. The following are exceptions to this criterion:
+Current or prior use of immunosuppressive medication within  days before the first dose of study drugs
+Current or prior use of immunosuppressive medication within  days prior to the first dose of IP. The following are exceptions to this criterion:
+Current or prior use of immunosuppressive medication within  days before start of treatment.
+Current or prior use of immunosuppressive medication within  days of first dose
+Current or prior use of immunosuppressive medication within  days before the first dose of their assigned Investigational Product;
+Current or prior use of immunosuppressive medication within  days prior to the first dose of MEDI. )
+Current or prior use of immunosuppressive medication within  days before the first dose of MEDI
+Current use of immunosuppressive medication at the time of study enrollment.
+Ongoing ? Grade  toxicities from previous cancer therapies unless specifically allowed in the Inclusion/Exclusion criteria. Use of immunosuppressive medication other than steroids within  days before the first dose of MEDI-
+Current use of systemic steroid medication
+Concurrent or prior use of immunosuppressive medication within  days;
+Concurrent or prior use of immunosuppressive medication within  days
+Use of immunosuppressive medication or systemic steroids within  days prior to first dose of MEDI
+Current or prior use of immunosuppressive medication within  days prior to the first dose of study treatment
+Current use of cytotoxic or immunosuppressive drugs
+Prior or current use of statin medication